1. Anti-mycobacterial Haliclonadiamine Alkaloids from the Okinawan Marine Sponge Haliclona Sp Collected at Iriomote Island. Abdjul, D.B., A. Yagi, H. Yamazaki, R. Kirikoshi, O. Takahashi, M. Namikoshi, and R. Uchida. Phytochemistry Letters, 2018. 26: p. 130-133. ISI[000438977200028].
[WOS]. TB_08_2018.
2. Antitubercular and Anti-inflammatory Properties Screening of Natural Products from Plectranthus Species. Andrade, J.M., L. Custódio, A. Romagnoli, C.P. Reis, M.J. Rodrigues, C. Garcia, E. Petruccioli, D. Goletti, C. Faustino, G.M. Fimia, and P. Rijo. Future Medicinal Chemistry, 2018. 10(14): p. 1677-1691. PMID[29957070]. PMCID[PMC6057328].
[PubMed]. TB_08_2018.
3. Antimycobacterial Activity and Safety Profile Assessment of Alpinia galanga and Tinospora cordifolia. Alajmi, M.F., R.A. Mothana, A.J. Al-Rehaily, and J.M. Khaled. Evidence-Based Complementary and Alternative Medicine, 2018. 2018(2934583): 12pp. PMID[30069222]. PMCID[PMC6057328].
[PubMed]. TB_08_2018.
4. An Efficient Synthetic Route for Preparation of Antimycobacterial Wollamides and Evaluation of Their in Vitro and in Vivo Efficacy. Asfaw, H., T. Wetzlar, M.S. Martinez-Martinez, and P. Imming. Bioorganic & Medicinal Chemistry Letters, 2018. 28(17): p. 2899-2905. PMID[30031620].
[PubMed]. TB_08_2018.
5. Structure-based Design of Some Isonicotinic acid Hydrazide Analogues as Potential Antitubercular Agents. Atta, A., S. Fahmy, O. Rizk, D. Sriram, M.A. Mahran, and I.M. Labouta. Bioorganic Chemistry, 2018. 80: p. 721-732. PMID[30077175].
[PubMed]. TB_08_2018.
6. Microwave-assisted Synthesis of Novel Benzodifuran-based bis(N-(het)Arylthiazol-2-amine) Derivatives and Their Antibacterial and Antimycobacterial Activities. Baba, N.H.K., D. Ashok, B.A. Rao, M. Sarasija, and N.Y.S. Murthy. Chemistry of Heterocyclic Compounds, 2018. 54(6): p. 658-663. ISI[000441231900015].
[WOS]. TB_08_2018.
7. Triazole-diindolylmethane Conjugates as New Antitubercular Agents: Synthesis, Bioevaluation, and Molecular Docking. Danne, A.B., A.S. Choudhari, S. Chakraborty, D. Sarkar, V.M. Khedkar, and B.B. Shingate. MedChemComm, 2018. 9(7): p. 1114-1130. PMID[30108999]. PMCID[PMC6072531].
[PubMed]. TB_08_2018.
8. Dual-protected Amino acid Derivatives as New Antitubercular Agents. de Castro, P.P., D.L. Campos, F.R. Pavan, and G.W. Amarante. Chemical Biology & Drug Design, 2018. 92(2): p. 1576-1580. PMID[29679451].
[PubMed]. TB_08_2018.
9. Synthesis and Biological Evaluation of Some Novel Quinoline Based Pyrimidine Derivatives. Desai, N.C., G.M. Kotadiya, and D.V. Vaja. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2018. 57(7): p. 965-973. ISI[000440123600004].
[WOS]. TB_08_2018.
10. Rauvolfianine, a New Antimycobacterial Glyceroglycolipid and Other Constituents from Rauvolfia caffra. Sond (Apocynaceae). Ebeh Messanga, R., N.B. Dominique Serge, A.Z.A. Abouem, M.N.I. Norbert, M.N. Esther Del Florence, B.D. Patrick Herve, N. Maximilienne Ascension, A. Alex De Theodore, P. Dieudonne Emmanuel, G.B. Christian, and U. Koert. Natural Product Research, 2018. 32(16): p. 1971-1976. PMID[28812370].
[PubMed]. TB_08_2018.
11. Boldine-derived Alkaloids Inhibit the Activity of DNA Topoisomerase I and Growth of Mycobacterium tuberculosis. Garcia, M.T., D. Carreño, J.M. Tirado-Vélez, M.J. Ferrándiz, L. Rodrigues, B. Gracia, M. Amblar, J.A. Ainsa, and A.G. de la Campa. Frontiers in Microbiology, 2018. 9(1659): 9pp. PMID[30087665]. PMCID[PMC6066988].
[PubMed]. TB_08_2018.
12. Cinnamoyl-oxaborole amides: Synthesis and Their in Vitro Biological Activity. Gumbo, M., R.M. Beteck, T. Mandizvo, R. Seldon, D.F. Warner, H.C. Hoppe, M. Isaacs, D. Laming, C.C. Tam, L.W. Cheng, N. Liu, K.M. Land, and S.D. Khanye. Molecules, 2018. 23(8). E2038. PMID[30111695].
[PubMed]. TB_08_2018.
13. Antimycobacterial, Enzyme Inhibition, and Molecular Interaction Studies of Psoromic acid in Mycobacterium tuberculosis: Efficacy and Safety Investigations. Hassan, S.T.S., M. Sudomova, K. Berchova-Bimova, S. Gowrishankar, and K.R.R. Rengasamy. Journal of Clinical Medicine, 2018. 7(8). E226. PMID[30127304]. PMCID[PMC6111308].
[PubMed]. TB_08_2018.
14. Synthesis and Tuberculostatic Activity of 2-Alkyl-5-aryltetrazoles. Ishmetova, R.I., S.G. Tolshchina, N.K. Ignatenko, M.A. Kravchenko, S.N. Skornyakov, G.L. Rusinov, and V.N. Charushin. Pharmaceutical Chemistry Journal, 2018. 52(4): p. 304-307. ISI[000439949300004].
[WOS]. TB_08_2018.
15. Design, Synthesis and Biological Evaluation of Novel Pyrrole Derivatives as Potential ClpP1P2 Inhibitor against Mycobacterium tuberculosis. Liu, P., Y. Yang, Y. Ju, Y. Tang, Z. Sang, L. Chen, T. Yang, Q. An, T. Zhang, and Y. Luo. Bioorganic Chemistry, 2018. 80: p. 422-432. PMID[30005200].
[PubMed]. TB_08_2018.
16. Identification of N-Benzyl 3,5-dinitrobenzamides Derived from PBTZ169 as Antitubercular Agents. Li, L., K. Lv, Y. Yang, J. Sun, Z. Tao, A. Wang, B. Wang, H. Wang, Y. Geng, M. Liu, H. Guo, and Y. Lu. ACS Medicinal Chemistry Letters, 2018. 9(7): p. 741-745. PMID[30034611]. PMCID[PMC6047030].
[PubMed]. TB_08_2018.
17. Synthesis, Structure and Bioactivity of Primary Sulfamate-containing Natural Products. Mujumdar, P., S. Bua, C.T. Supuran, T.S. Peat, and S.A. Poulsen. Bioorganic & Medicinal Chemistry Letters, 2018. 28(17): p. 3009-3013. PMID[29685656].
[PubMed]. TB_08_2018.
18. Ultrasound Assisted Synthesis of 4-(Benzyloxy)-N-(3-chloro-2-(substitutedphenyl)-4-oxoazetidin-1-yl) benzamide as Challenging Anti-tubercular Scaffold. Nimbalkar, U.D., J.A. Seijas, R. Borkute, M.G. Damale, J.N. Sangshetti, D. Sarkar, and A.P.G. Nikalje. Molecules, 2018. 23(8): E1945. PMID[30081525].
[PubMed]. TB_08_2018.
19. Synthesis and Spectrum of Biological Activities of Novel N-Arylcinnamamides. Pospisilova, S., J. Kos, H. Michnova, I. Kapustikova, T. Strharsky, M. Oravec, A.M. Moricz, J. Bakonyi, T. Kauerova, P. Kollar, A. Cizek, and J. Jampilek. International Journal of Molecular Sciences, 2018. 19(8). E2318. PMID[30087309]. PMCID[PMC6121455].
[PubMed]. TB_08_2018.
20. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination. Pryjma, M., J. Burian, and C.J. Thompson. Antimicrobial Agents and Chemotherapy, 2018. 62(8). e00283-18. PMID[29760147]. PMCID[PMC6105836].
[PubMed]. TB_08_2018.
21. In Vitro Antimycobacterial Activity of 2-(((2-Hydroxyphenyl)amino)methylene)-5,5-dimethylcyclohexane-1,3-dione: A New Chemical Entity against Mycobacterium tuberculosis. Rather, M.A., Z.S. Bhat, A.M. Lone, M. Maqbool, S. Amin, B.A. Bhat, and Z. Ahmad. International Journal of Antimicrobial Agents, 2018. 52(2): p. 265-268. PMID[29510188].
[PubMed]. TB_08_2018.
22. Copper-related Toxicity in Replicating and Dormant Mycobacterium tuberculosis Caused by 1-Hydroxy-5-R-pyridine-2(1H)-thiones. Salina, E.G., S. Huszár, J. Zemanová, J. Keruchenko, O. Riabova, E. Kazakova, A. Grigorov, T. Azhikina, A. Kaprelyants, K. Mikušová, and V. Makarov. Metallomics, 2018. 10(7): p. 992-1002. PMID[29946601].
[PubMed]. TB_08_2018.
23. Structural Comparison of Mtb-DHFR and h-DHFR for Design, Synthesis and Evaluation of Selective Non-pteridine Analogues as Antitubercular Agents. Sharma, K., O. Tanwar, S. Sharma, S. Ali, M.M. Alam, M.S. Zaman, and M. Akhter. Bioorganic Chemistry, 2018. 80: p. 319-333. PMID[29986181].
[PubMed]. TB_08_2018.
24. Synthesis and Antimycobacterial Evaluation of Piperazyl-Alkyl-Ether Linked 7-Chloroquinoline-chalcone/Ferrocenyl chalcone Conjugates. Singh, A., A. Viljoen, L. Kremer, and V. Kumar. ChemistrySelect, 2018. 3(29): p. 8511-8513. ISI[000440910300015].
[WOS]. TB_08_2018.
25. Identification and Characterization of Aspartyl-tRNA Synthetase Inhibitors against Mycobacterium tuberculosis by an Integrated Whole-cell Target-based Approach. Soto, R., E. Perez-Herran, B. Rodriguez, B.M. Duma, M. Cacho-Izquierdo, A. Mendoza-Losana, J. Lelievre, D.B. Aguirre, L. Ballell, L.R. Cox, L.J. Alderwick, and G.S. Besra. Scientific Reports, 2018. 8(12664): 9pp. PMID[30140040]. PMCID[PMC6107548].
[PubMed]. TB_08_2018.
26. Design, Synthesis, and in Vitro Anti-mycobacterial Activities of Propylene-tethered Gatifloxacin-Isatin Hybrids. Wang, H.D., Y.L. Fan, J. Zhou, Y. Xu, and J. Guan. Journal of Heterocyclic Chemistry, 2018. 55(8): p. 1991-1996. ISI[000441694400020].
[WOS]. TB_08_2018.
27. Design, Synthesis and Antimycobacterial Activity of 3,5-Dinitrobenzamide Derivatives Containing Fused Ring Moieties. Wang, A., G. Huang, B. Wang, K. Lv, H. Wang, Z. Tao, M. Liu, H. Guo, and Y. Lu. Bioorganic & Medicinal Chemistry Letters, 2018. 28(17): p. 2945-2948. PMID[30006066].
[PubMed]. TB_08_2018.
28. Synthesis, Biological Evaluation and Computational Study of New Quinoline Hybrids as Antitubercular Agent. Zaheer, Z., S.I. Shaikh, S.M. Mokale, and D.K. Lokwani. Letters in Drug Design & Discovery, 2018. 15(9): p. 914-922. ISI[000438897300001].
[WOS]. TB_08_2018.
29. Design, Synthesis, and Biological Evaluation of m-Amidophenol Derivatives as a New Class of Antitubercular Agents. Zhang, N.N., Z.Y. Liu, J. Liang, Y.X. Tang, L. Qian, Y.M. Gao, T.Y. Zhang, and M. Yan. MedChemComm, 2018. 9(8): p. 1293-1304. PMID[30151083]. PMCID[PMC6096355].
[PubMed]. TB_08_2018.
Patent Citations
30. Compounds for Treating Tuberculosis. Grueber, G., R.W. Bates, A. Hotra, T. Dick, and K. Pethe. Patent. 2018. 2018-SG50075 2018151681: 67pp.
[Patent]. TB_08_2018.
31. Phenazine Derivatives as Antimicrobial Agents. Huigens, R.W., A. Garrison, Y. Abouelhassan, H. Yang, and G. Burch. Patent. 2018. 2018-US18538 2018152436: 237pp.
[Patent]. TB_08_2018.
32. Pleuromutilin Derivatives and Uses Thereof. Kurosu, M. and K. Mitachi. Patent. 2018. 2018-US18503 2018152408: 102pp.
[Patent]. TB_08_2018.
33. Pharmaceutical Composition for Preventing or Treating Mycobacterium Species Infection and Method Using the Same. Oh, D.C., Y.H. Shin, E.K. Jo, H.M. Lee, T.S. Kim, and W. Kim. Patent. 2018. 2018-15887862 20180221437: 23pp.
[Patent]. TB_08_2018.